InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Saturday, 01/07/2023 11:07:36 AM

Saturday, January 07, 2023 11:07:36 AM

Post# of 461853
Listening to my Mom describe many of her friends’ families saying they’d opt for anything rather than continuing to see declines is just mortifying. Hopefully 2-73 and 3-71 are expedited, because their SAFETY along with their EFFICACY are top notch.

Pity those recipients of Lecanemab - LEQEMBI who will die because of the shady relationships between Biogen/Easai and certain FDA members trumped safety.

Changing the drug’s name to avoid negative associations is a thug maneuver.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News